Atlas Trials

Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy

Clinical trial NCT00076206 · TERMINATED

Trial details

NCT number
NCT00076206
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2003-12-01
Primary completion
2005-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.